Gambia says child deaths linked to cough syrup have risen to 70

Gambia's president-elect Adama Barrow in a file photo. Picture taken December 5, 2021. REUTERS/Zohra Bensemra/File Photo

BANJUL, Oct 14 (Reuters) – Gambia’s government on Friday said the number of child deaths from acute kidney injury, thought to be linked to Indian-made cough syrups, has risen to 70 from a previous toll of 69.

President Adama Barrow gave the update at an emergency cabinet meeting which he convened on Thursday to discuss the crisis, according to a presidency statement.

The syrups were found to be made by New Delhi-based Maiden Pharmaceuticals Ltd, which has since had one of its factories shut down in northern India as health authorities there investigate.

Logo of the Maiden Pharmaceuticals Ltd. company is seen on a board outside their office in New Delhi, India, October 6, 2022. REUTERS/Anushree Fadnavis/File Photo/File Photo

Gambia is also investigating the deaths and this week set up a new commission of inquiry to deal with them, the statement said.

Reporting by Pap Saine; Writing by Nellie Peyton; Editing by Chris Reese

Our Standards: The Thomson Reuters Trust Principles.

Source: Reuters


Please enter your comment!
Please enter your name here